Inhibrx Biosciences (INBX) Share-based Compensation (2023 - 2025)
Inhibrx Biosciences (INBX) recorded Share-based Compensation of $2.74 million in Q4 2025, down 8.0% from $2.98 million a year earlier and down 13.6% from the prior quarter.
Powered by 
Analysis
Inhibrx Biosciences (INBX) Share-based Compensation (2023 - 2025) Analysis & Trends
For FY2025, Inhibrx Biosciences reported Share-based Compensation of $11.14 million, down 81.0% from FY2024.
- Across earlier years, Share-based Compensation came in at $58.52 million in FY2024 (+135.5%) and $24.85 million in FY2023.
- Quarterly Share-based Compensation has ranged from $2.45 million in Q1 2025 to $46.17 million in Q2 2024 over the past five years.
- On a year-over-year basis, Share-based Compensation rose in 1 of the last six quarters, with an average decline of 44.1%.
- Per Business Quant, the preceding three quarters came in at $3.18 million (Q3 2025), $2.77 million (Q2 2025) and $2.45 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Inhibrx Biosciences | 1.52 Bn | 923.96 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 2.74 Mn |
| Sep 30, 2025 | 3.18 Mn |
| Jun 30, 2025 | 2.77 Mn |
| Mar 31, 2025 | 2.45 Mn |
| Dec 31, 2024 | 2.98 Mn |
| Sep 30, 2024 | 2.97 Mn |
| Jun 30, 2024 | 46.17 Mn |
| Mar 31, 2024 | 6.40 Mn |
| Dec 31, 2023 | 6.43 Mn |
| Sep 30, 2023 | 6.53 Mn |
API Access
Inhibrx Biosciences Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=INBX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "INBX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=INBX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();